Axa’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-903,425
Closed -$1.11M 1432
2018
Q4
$1.11M Hold
903,425
﹤0.01% 950
2018
Q3
$3.6M Buy
903,425
+215,989
+31% +$1.31M 0.01% 752
2018
Q2
$5.95M Buy
687,436
+72,297
+12% +$881K 0.02% 610
2018
Q1
$7.97M Buy
615,139
+172,218
+39% +$1.95M 0.03% 521
2017
Q4
$4.76M Buy
442,921
+362,337
+450% +$4.55M 0.02% 665
2017
Q3
$1.28M Sell
80,584
-123,106
-60% -$2.34M 0.01% 907
2017
Q2
$4.43M Sell
203,690
-59,351
-23% -$1.36M 0.02% 634
2017
Q1
$6.64M Sell
263,041
-4,803
-2% -$98.7K 0.03% 539
2016
Q4
$3.49M Hold
267,844
0.02% 648
2016
Q3
$1.28M Hold
267,844
0.01% 851
2016
Q2
$1.01M Sell
267,844
-274,889
-51% -$956K ﹤0.01% 864
2016
Q1
$1.5M Hold
542,733
0.01% 801
2015
Q4
$3.12M Sell
542,733
-11,408
-2% -$65.5K 0.01% 685
2015
Q3
$3.19M Buy
554,141
+151,677
+38% +$1.03M 0.01% 676
2015
Q2
$2.43M Buy
402,464
+122,873
+44% +$762K 0.01% 754
2015
Q1
$2.73M Buy
279,591
+17,093
+7% +$193K 0.01% 729
2014
Q4
$3.43M Buy
262,498
+16,795
+7% +$171K 0.01% 660
2014
Q3
$2.2M Buy
245,703
+38,657
+19% +$396K 0.01% 720
2014
Q2
$2.89M Buy
207,046
+40,000
+24% +$560K 0.01% 684
2014
Q1
$2.58M Buy
+167,046
New +$2.89M 0.01% 700

Other funds holding AKAO

Axa's AKAO Position: Q1 2019 in Review

Axa sold out of Achaogen Inc (AKAO) in Q1 2019, closing a stake of 903,425 shares — an estimated $1.11M sold.

Axa first reported a position in AKAO in Q1 2014 and held it in 20 quarters. The position peaked at $7.97M in Q1 2018. 70 funds tracked by Wall St. Rank hold AKAO as of Q1 2019.

  • Axa reported no remaining Achaogen Inc position as of Q1 2019 after selling out during the quarter.
  • Axa sold 903,425 Achaogen Inc shares in Q1 2019, an estimated $1.11M.
  • Axa first reported a position in Achaogen Inc in Q1 2014 and held it in 20 quarters.
  • Axa's Achaogen Inc position peaked at $7.97M in Q1 2018.
  • 70 funds tracked by Wall St. Rank held Achaogen Inc as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.